Table 2 Proposed ATTR staging utilizing the staging tool proposed by Gillmore et al. [67]
From: Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers
Number of abnormal laboratory tests | Stage (according to revised staging system) | Median Overall Survival (months) | 5-year Survival |
|---|---|---|---|
0 | I | 69.2 | 63% |
1 | II | 46.7 | 37% |
2 | III | 24.1 | 19% |